Michael Hemmer

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide”.

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.05.001

N/A

0DataRank · unranked

66 citations

Armin Rashidi, Tao Wang, Michael Hemmer, Margaret L. MacMillan, Joseph Pidala +66 more

Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host Disease

Transplantation and Cellular Therapy(2020)10.1016/j.jtct.2020.10.012

N/A

0DataRank · unranked

26 citations

Yimei Li, Kelly Getz, Michael Hemmer, Yuan-Shung Huang, Matt Hall +21 more

Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.07.013

N/A

0DataRank · unranked

32 citations

Amin M. Alousi, Joseph Pidala, Mukta Arora, Stephen R. Spellman, Michael Hemmer +37 more